Pharmacogenetics of Psychotropic Drug Response
- 1 May 2004
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 161 (5) , 780-796
- https://doi.org/10.1176/appi.ajp.161.5.780
Abstract
OBJECTIVE: Molecular genetic approaches provide a novel method of dissecting the heterogeneity of psychotropic drug response. These pharmacogenetic strategies offer the prospect of identifying biological predictors of psychotropic drug response and could provide the means of determining the molecular substrates of drug efficacy and drug-induced adverse events. METHOD: The authors discuss methods issues in executing pharmacogenetic studies, review the first generation of pharmacogenetic studies of psychotropic drug response, and consider future directions for this rapidly evolving field. RESULTS: Pharmacogenetics has been most commonly used in studies of antipsychotic drug efficacy, antidepressant drug response, and drug-induced adverse effects. Data from antipsychotic drug studies indicate that polymorphisms within the serotonin 2A and dopamine receptor 2 genes may influence drug efficacy in schizophrenia. Moreover, a growing body of data suggests a relationship between the serotonin transporter gene and ...Keywords
This publication has 140 references indexed in Scilit:
- The Role of Serotonin Transporter Protein Gene in Antidepressant-Induced Mania in Bipolar DisorderArchives of General Psychiatry, 2001
- Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood plateletsAmerican Journal of Medical Genetics, 1999
- Fatality associated with combined fluoxetine-amitriptyline therapy.JAMA, 1997
- The Effects of a Selective D4 Dopamine Receptor Antagonist (L-745,870) in Acutely Psychotic Inpatients With SchizophreniaArchives of General Psychiatry, 1997
- Search for a Susceptibility Locus to Tardive DyskinesiaHuman Psychopharmacology: Clinical and Experimental, 1997
- Assessment of association of D3 dopamine receptorMscI polymorphism with schizophrenia: Analysis of symptom ratings, family history, age at onset, and movement disordersAmerican Journal of Medical Genetics, 1996
- Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to ClozapineArchives of General Psychiatry, 1994
- No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresisJAMA, 1994
- Neuroleptic Responsiveness in Siblings Concordant for SchizophreniaArchives of General Psychiatry, 1989
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988